Lack of association of statin use with vitamin D levels in a hospital based population of type 2 diabetes mellitus patients
- PMID: 29643908
- PMCID: PMC5857014
- DOI: 10.12669/pjms.341.11977
Lack of association of statin use with vitamin D levels in a hospital based population of type 2 diabetes mellitus patients
Abstract
Objective: To investigate the relationship of statins (drug given to reduce serum levels of LDL-cholesterol) on vitamin D levels of Pakistani type 2 diabetes mellitus (DM) patients in a hospital in Karachi.
Methods: In a cross-sectional survey, 312 consecutive patients with type 2 DM (219 males and 93 females, age 22-70 years) were recruited with informed consent. A questionnaire was administered to find out whether they were statin users or non-users. Serum was analyzed for concentrations of 25(OH) vitamin D [25(OH)D] and other related biomarkers such as serum cholesterol, triglycerides, HDL-cholesterol, LDL-cholesterol, phosphate and calcium using kit methods. Multiple Linear Regression was used to evaluate association of statin use with serum levels of vitamin D while adjusting for related covariates including duration of statin use, duration of type 2 DM and smoking.
Results: Mean concentrations of serum cholesterol, and LDL-cholesterol were lower among statin users compared to statin non-users (P < 0.01), while HDL-cholesterol levels were higher (P<0.01). No relationship was observed between statin use and serum levels of vitamin D (P=0.768), when adjusted for age, gender, BMI, duration of type 2 DM, smoking, serum cholesterol and LDL-cholesterol. The adjusted regression coefficient (β) and standard error [SE(β)] for statin use duration were 0.012 (0.042), when serum levels of vitamin D was taken as an outcome.
Conclusion: Lack of association was found between statin use and vitamin D levels in a hospital-based population of Pakistani patients with type 2 DM.
Keywords: Diabetes mellitus; Pakistani population; Statins; Vitamin D levels.
Conflict of interest statement
Conflict of Interest: The authors declare that there are no conflicts of interest.
Similar articles
-
Relationship Between Statin-associated Muscle Symptoms, Serum Vitamin D and Low-density Lipoprotein Cholesterol - A Cross-sectional Study.Eur Endocrinol. 2020 Oct;16(2):137-142. doi: 10.17925/EE.2020.16.2.137. Epub 2020 Oct 6. Eur Endocrinol. 2020. PMID: 33117445 Free PMC article.
-
Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome.Curr Med Res Opin. 2004 Sep;20(9):1437-45. doi: 10.1185/030079904x2321. Curr Med Res Opin. 2004. PMID: 15383192 Clinical Trial.
-
Symptomatic myositis-myalgia in hypercholesterolemic statin-treated patients with concurrent vitamin D deficiency leading to statin intolerance may reflect a reversible interaction between vitamin D deficiency and statins on skeletal muscle.Med Hypotheses. 2011 Oct;77(4):658-61. doi: 10.1016/j.mehy.2011.07.007. Epub 2011 Jul 29. Med Hypotheses. 2011. PMID: 21802861
-
Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids.Prog Lipid Res. 2011 Oct;50(4):303-12. doi: 10.1016/j.plipres.2011.05.001. Epub 2011 May 27. Prog Lipid Res. 2011. PMID: 21640757 Review.
-
2017 Taiwan lipid guidelines for high risk patients.J Formos Med Assoc. 2017 Apr;116(4):217-248. doi: 10.1016/j.jfma.2016.11.013. Epub 2017 Feb 24. J Formos Med Assoc. 2017. PMID: 28242176 Review.
Cited by
-
The Interdependency and Co-Regulation of the Vitamin D and Cholesterol Metabolism.Cells. 2021 Aug 6;10(8):2007. doi: 10.3390/cells10082007. Cells. 2021. PMID: 34440777 Free PMC article. Review.
-
Association of 25-hydroxyvitamin D levels with lipid profiles in osteoporosis patients: a retrospective cross-sectional study.J Orthop Surg Res. 2023 Aug 14;18(1):597. doi: 10.1186/s13018-023-04079-8. J Orthop Surg Res. 2023. PMID: 37574564 Free PMC article.
-
The Effect of Statins on Serum Vitamin D Concentrations Among Older Adults.Cureus. 2020 Jul 1;12(7):e8950. doi: 10.7759/cureus.8950. Cureus. 2020. PMID: 32765995 Free PMC article.
References
-
- Ray KK, Kastelein JJ, Boekholdt SM, Nicholls SJ, Khaw KT, Ballantyne CM, et al. The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011. Eur Heart J. 2014;35:960–968. doi:10.1093/eurhearty/ehu107. - PubMed
-
- Zittermann A, Gummert JF, Borgermann JH. The role of vitamin D in dyslipidemia and cardiovascular disease. Curr Pharm Des. 2011;17:933–942. - PubMed
-
- Akhtar S. Vitamin D status of South Asian populations – risks and opportunities. Crit Rev Food Sci Nutr. 2016;56(11):1925–1940. doi:10.1080/10408398.2013.807419. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources